Modafinil can improve memory in patients recovering from depression, suggests new research from the University of Cambridge. The findings offer hope of a treatment for some of the cognitive symptoms of depression.
The results come from a randomised, double-blind, placebo-controlled study looking at the potential of modafinil to treat cognitive dysfunction in depression. Modafinil is a drug used to treat narcolepsy, excessive daytime sleepiness. Modafinil has already been shown in other studies to have beneficial effects on cognitive function in psychiatric disorders such as schizophrenia.
Depression, one of the leading causes of disability worldwide is characterized by symptoms such as difficulty concentrating or indecisiveness contribute to the disability associated with depression.
Almost all patients with depression experience problems with concentration, memory, and attention. At least half of all patients with depression show cognitive deficits that can be measured objectively. These deficits tend to persist in the recovery phase.
Depression Cognitive Deficits
Patients with persistent cognitive problems have poorer outcomes such as impaired work functioning and increased risk for relapse. Depression can be relapsing and return periodically, often for several months at a time.
Depression is associated with taking time off work, but also, in some cases, with ‘presenteeism’ in the workplace, where employees may not be able to work as well as usual. People often feel distressed when they have difficulty achieving their previous level of work performance on return to work after experiencing depression.
However, currently available treatments do not specifically address cognitive deficits in depression. Recent reports have highlighted the importance of defining cognition as a target for treatment in depression.
Sixty patients aged between 18 and 65 years with remitted depression completed computerised memory, attention and planning tasks after receiving modafinil or a placebo.
Modafinil Memory Function Improvement
The results showed that patients given a dose of modafinil experienced improvements in memory functions, compared to those patients on placebo. Specifically, patients had benefits in two types of memory — episodic memory and working memory, both of which are important in our day-to-day activities.
Professor Barbara Sahakian, the study’s senior author, explains:
“We use episodic memory when we are remembering where we left our keys in the house, or remembering where we parked our car. Working memory, on the other hand, is the ability we use when we are rehearsing a new telephone number while we are trying to find a pen and paper to write it down, for example.”
The study demonstrated that patients receiving modafinil made fewer errors than those who received a placebo. For example, in one of the tasks which involved remembering the location among an increasing number of boxes of a particular pattern, patients receiving modafinil made fewer than half the number of mistakes that those receiving the placebo made, at the most difficult level.
It is not clear from the study whether the same effects would be seen over the long term, say the researchers. Professor Sahakian adds:
“We now need a longer term study using modafinil to see if the drug, which improves cognition and motivation, can facilitate successful return to work following depression.”
Muzaffer Kaser et al
Modafinil Improves Episodic Memory and Working Memory Cognition in Patients With Remitted Depression: A Double-Blind, Randomized
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging (2016). DOI: 10.1016/j.bpsc.2016.11.009
Image: Chris Nurse, Wellcome Images